Multiplex Tandem Mass Spectrometry Analysis of Novel Plasma Lyso-Gb3-Related Analogues in Fabry Disease-Reference-Cited by-同舟云学术

Multiplex Tandem Mass Spectrometry Analysis of Novel Plasma Lyso-Gb3-Related Analogues in Fabry Disease

Published:2014-03-17 Issue:7 Volume:86 Page:3476-3483
ISSN:0003-2700
Container-title:Analytical Chemistry
language:en
Short-container-title:Anal. Chem.

Author:

Boutin Michel¹,Auray-Blais Christiane¹

Affiliation:

1. Service of Genetics, Department of Pediatrics, Faculty of Medicine and Health Sciences, Université de Sherbrooke, 3001 12th Avenue North, Sherbrooke, Québec J1H 5N4, Canada

Funder

Genzyme

Canadian Institutes of Health Research

Publisher

American Chemical Society (ACS)

Subject

Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ac404000d

Reference20 articles.

1. Narrative Review: Fabry Disease

2. Fabry disease

3. Fabry Disease Cardiomyopathy: from Genes to Clinical Manifestations

4. Enzyme replacement therapy for Fabry disease: a systematic review and meta-analysis

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of high-performance thin layer chromatography mass spectrometry (HPTLC MS) in foodomics authenticity;Talanta Open;2024-08

2. LysoGb3 quantification facilitates phenotypic categorization of Fabry disease patients: Insights gained by a novel MS/MS method;Clinica Chimica Acta;2024-07

3. Towards personalized genome-scale modeling of inborn errors of metabolism for systems medicine applications;Metabolism;2024-01

4. Fabry Disease in Women: Genetic Basis, Available Biomarkers, and Clinical Manifestations;Genes;2023-12-26

5. Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study;Journal of Medical Genetics;2023-11-08